The largest database of trusted experimental protocols

15 protocols using sil 20ac autoinjector

1

Quantitative Lipid Mediator Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatant from the inflammatory lesions were placed in ice cold methanol containing deuterated internal standards (d8-5S-hydroxyeicosatetraenoic acid (HETE), d4-leukotriene (LT) B4, d4-prostaglandin (PG)E2 and d5-lipoxin (LX) A4; 500pg each) and homogenized using a PTFE dounce (Kimble Chase). Proteins were allowed to precipitate (4°C), and lipid mediators were extracted using C18 solid-phase cartridges and a Biotage RapidTrace®. Measurement of lipid mediators was carried out by liquid chromatography-tandem mass spectrometry using a QTrap 5500 (ABSciex, Framingham, MA) equipped with a Shimadzu LC-20AD HPLC and a Shimadzu SIL-20AC autoinjector (Shimadzu, Kyoto, Japan). An Agilent Eclipse Plus C18 column (100mm × 4.6 mm × 1.8 μm) maintained at 50°C was used with a gradient of methanol/water/acetic acid of 55:45:0.01 (v/v/v) to 100:0:0.01 at 0.4 ml/min flow rate. Multiple reactions monitoring (MRM) was used to monitor lipid mediator profiles with more than 60 bioactive products from specific biosynthetic pathway including their pathway markers. Identification was carried out with signature ion fragments for each target lipid mediator (pro-inflammatory mediators PG, LT as well as SPM) using a minimum of six diagnostic ions. Quantification was achieved using calibration curves (Colas et al., 2014 (link)).
+ Open protocol
+ Expand
2

Quantification of Lipid Mediators by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Media and lysate samples were stored at −80 °C prior to analysis. 2 volumes of ice cold MeOH containing deuterated internal standards (d4-LTB4, d8-5S-HETE, d4-PGE2, d5-LXA4 and d5-RvD2, 500 pg each) were added to the samples. These were then kept at −20 °C for 45 minutes to allow for protein precipitation and subjected to solid phase extraction as per previous publication26 (link). Methyl formate fractions were then brought to dryness using a TurboVap LP (Biotage) and products suspended in water-methanol (50:50 vol:vol) for LC-MS-MS. A Shimadzu LC-20AD HPLC and a Shimadzu SIL-20AC autoinjector (Shimadzu, Kyoto, Japan), paired with a QTrap 5500 (ABSciex, Warrington, UK) were utilised and operated as described26 (link). To monitor each lipid mediator and respective pathways, a Multiple Reaction Monitoring (MRM) method was developed with diagnostic ion fragments and identification using recently published criteria26 (link), including matching retention time (RT) to synthetic and authentic materials and at least six diagnostic ions for each lipid mediator. Calibration curves were obtained for each using authentic compound mixtures and deuterium labeled lipid mediator at 0.78, 1.56, 3.12, 6.25, 12.5, 25, 50, 100, and 200 pg. Linear calibration curves were obtained for each lipid mediator, which gave r2 values of 0.98–0.99.
+ Open protocol
+ Expand
3

Quantification of FTC in Pharmaceutical Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
FTC content in PLS-FTC was determined using a sodium hydroxide degradation sample preparation and HPLC/PDA analytical method (Figure 9; Figure S14,15; Table S1). PLS-FTC and FTC standards were prepared in 50% acetonitrile in water. 150 μL of each sample was treated with 10 μL 1N NaOH for 1 h to completely hydrolyze all esters, followed by neutralization with 10 μL 1N HCl. A set of non-degraded FTC standards were prepared by taking 150 μL of each standard and adding 20 μL water. The samples were analyzed by an HPLC/PDA system consisting of an LC-20AT pump, SIL-20AC auto injector, CTO-20AC column oven, SPD-M20A diode array detector, and C-R3A integrator (Shimadzu Scientific Instruments, Inc.). The HPLC conditions for the NaOH-treated samples were: 10 μL injection volume with a 50% acetonitrile in ammonium acetate (20 mM, pH 5) isocratic elution. Flow rate was 0.600 mL/min, and column temperature was 35 °C. PDA monitored at 280 nm. The column used was Zorbax SB C18 4.6 mm id x 15 cm.
+ Open protocol
+ Expand
4

Quantification and Profiling of Biomolecules by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
The LC-MS/MS system included a Shimadzu LC-20AD HPLC and a Shimadzu SIL-20AC autoinjector (Shimadzu) paired with a QTrap 5500 (ABSciex) coupled to a Poroshell 120 EC column (100 mm × 4.6 mm × 2.7 µm; Agilent) maintained at 50 °C using a column oven (ThermaSphere TS-130; Phenomenex) employed for identification and quantification. For product profiling the following mobile phase was employed: MeOH/H2 O/acetic acid of 55:45:0.1 (vol:vol:vol) with a gradient ramped to 80:20:0.1 (vol:vol:vol) for 8 min, that was held for 3 min and then ramped to 98:2:0.1 (vol:vol:vol) for the next 0.1 min and maintained at 98:2:0.1 (vol:vol:vol) for 4 min, with a flow rate maintained at 0.6 mL/min. The QTrap 5500 was operated in negative ionization mode using scheduled multiple reaction monitoring coupled with information-dependent acquisition (IDA) and an enhanced product ion scan (EPI).
+ Open protocol
+ Expand
5

HPLC Quantification of Cefdinir Drug

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sample analysis was performed using a Shimadzu HPLC system consisting of LC-20AT pump, SIL-20AC autoinjector, CBM-20A communication bus module, CTO-20A column oven, and SPD-M20A diode array detector (Shimadzu, Kyoto, Japan). The separation of cefdinir was performed on a reverse phase C18 column (250 mm × 4.6 mm, 5 μm; Shiseido, Tokyo, Japan). The mobile phase consisted of 1 M tetramethylammonium hydroxide solution, water, 0.1 M ethylenediaminetetraacetic acid, and methanol (1.40:92.40:0.04:6.16, v/v/v/v) (pH 5, adjusted with diluted phosphoric acid), at a flow rate of 1.0 mL/min by modifying method in United States Pharmacopoeia (USP) (2010) [23 ]. The column and autosampler tray were maintained at 40 °C and 4 °C, respectively. The analytical run time was 10 min. UV detection was monitored at 254 nm and injection volume of sample was 10 μL. Data acquisition and processing were carried out using the Shimadzu LC Solution software.
+ Open protocol
+ Expand
6

Quantitative Lipid Mediator Profiling by LC-MS/MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deuterated internal standards d8-5S-HETE, d4-LTB4, d5-LXA4, d4-PGE2 and d5-RvD2 representing each chromatographic region of identified LM (500 pg each) were added to samples to facilitate quantification. Samples were extracted by solid phase extraction on C18 columns as in Dalli and Serhan (12 (link)) and subjected to LC-MS-MS. The system consisted of a QTrap 5500 (ABSciex) equipped with Shimadzu LC-20AD HPLC and a Shimadzu SIL-20AC autoinjector (Shimadzu Corp., Kyoto, Japan). An Agilent Eclipse Plus C18 column (100 mm×4.6 mm×1.8 μm) was used with a gradient of methanol/water/acetic acid of 55:45:0.01 (vol/vol/vol) to 100:0:0.01 at 0.4 mL/min flow rate. To monitor and quantify levels of targeted LM, a multiple reaction monitoring (MRM) method was developed with signature ion pairs, Q1 (parent ion) - Q3 (characteristic daughter ion) for each molecule (Figure 2 and Supplemental Table 1–3). Identification was conducted using published criteria (12 (link)) where a minimum of 6 diagnostic ions were employed. In case the synthetic or biogenic standard for a given LM was not available, calibration curve of the LM with most similar physical properties to the analyte was used. Linear calibration curve for each compound was obtained with r2 values ranging from 0.98–0.99 and detection limit was ~0.1 pg in this system.
+ Open protocol
+ Expand
7

Extraction and LC-MS/MS Profiling of Metabolites

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were placed in one volume of ice-cold MeOH containing deuterated internal standards (5 μg of 13C2-citrate, 5 μg of 13C2-fumarate, and 10 μg of 13C6-glucose) and homogenized. One volume of ice-cold water was added, followed by the addition of two volumes of chloroform. Samples were then centrifuged for 10 min at 4000g. Aqueous phase was collected and brought to dryness under a gentle nitrogen stream using TurboVap LV before suspension in H2O for LC-MS/MS profiling.
Extracted samples were analyzed using an LC-MS/MS system. Here, a QTrap 6500+ (Sciex) was equipped with a Shimadzu SIL-20 AC autoinjector and LC-20 AD binary pump (Shimadzu Corp.). Separation was conducted with a method adapted from (40 ). Briefly, a Synergi Hydro-RP column (250 mm by 4.6 mm by 4 μm, Phenomenex), maintained at 30°C, was used with a gradient of methanol/water/acetic acid of 0:100:0.5 (v/v/v) that was ramped to 100:0:0.5 (v/v/v) over 16 min. The flow rate was maintained at 0.5 ml/min. To monitor and quantify the levels of analytes, a multiple reaction monitoring method was used as in (41 (link)). Table S3 reports the transitions used for each of the molecules. Calibration curves were obtained using a mixture of standards for each of the molecules of interest with an r2 of 0.98.
+ Open protocol
+ Expand
8

HPLC Quantification of Tulearine

Check if the same lab product or an alternative is used in the 5 most similar protocols
TUL was measured using an HPLC method. A Shimadzu LC-20AT system equipped with an SIL-20AC auto-injector and a CTO-20 A column oven (Shimadzu Corp.) was used to measure the TUL content. TUL was dissolved in methanol containing internal standard (1 μg/mL methyl p-oxybenzoate), and 10 μL was injected into the HPLC. The column used was an Inertsil® ODS-3 column (3 μm, column size: 2.1 mm × 50 mm; GL Science Co., Inc., Tokyo, Japan), and 0.02 M potassium dihydrogen phosphate:acetonitrile (87:13, v/v) was utilized as the mobile phase at 0.25 mL/min and 35 °C. TUL was detected at 211 nm.
+ Open protocol
+ Expand
9

Lipidomic Analysis of Spinal Cord Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
For LC-MS/MS analysis, 2ml ice-cold methanol was added to each spinal cord and the samples were profiled using metabololipidomics as described previously (Colas et al., 2014 (link)). In short, for lipid mediator profiling deuterated internal standards d8–5S-HETE, d4-LTB4, d5-LXA4, d4-PGE2 and d5-RvD2 (500 pg each) representing each chromatographic region of identified lipid mediators were added to samples to perform quantification and assessment of sample recovery. Proteins were allowed to precipitate at ‒20°C overnight prior to centrifugation (1200 g at 4°C for 10 min) and then supernatants were taken to solid-phase extraction on C18 columns. Products were eluted using methyl formate, brought to dryness under nitrogen and suspended in methanol-water (50:50) for lipid mediators (Colas et al., 2014 (link)). The system consisted of a Qtrap 6500 (AB Sciex, Framingham, MA, USA) equipped with a Shimadzu SIL-20AC autoinjector, LC-20AD binary pump (Shimadzu, Kyoto, Japan), and an Agilent Eclipse Plus C18 column (100 mm x 4.6 mm x 1,8 μm). To identify and quantify lipid mediators, multiple reaction monitoring (MRM) was used with signature ion pairs Q1 (parent ion) to Q3 (characteristic daughter ion) for each molecule (Table 1). Identification was conducted by using published criteria with six diagnostic ions and retention time matching of standards (Colas et al., 2014 (link)).
+ Open protocol
+ Expand
10

HDL Particle Size Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate changes in HDL particle size, patient HDL fractions were analyzed on an HPLC system equipped with a LC-20ADVP pump, a DGU-20A degassing unit, a CTO-20A column oven, an SPD-20A ultraviolet detector, and an SIL-20AC autoinjector (Shimadzu Corporation, Kyoto, Japan). Each sample (40 μL) was injected into serially connected size exclusion columns (PROTEIN KW-803 and KW-804; 300 mm × 8.0 mm i.d., Shodex, Tokyo, Japan), eluted with PBS at a flow rate of 1 mL/min, and monitored by absorbance at 280 nm.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!